240 related articles for article (PubMed ID: 35293607)
21. Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis.
Yu B; Zhi X; Li Q; Li T; Chen Z
BMC Gastroenterol; 2023 Aug; 23(1):289. PubMed ID: 37612653
[TBL] [Abstract][Full Text] [Related]
22. Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis.
Kudo A; Tanaka S; Ban D; Matsumura S; Irie T; Ochiai T; Nakamura N; Arii S; Tanabe M
J Gastroenterol; 2014 Sep; 49(9):1352-61. PubMed ID: 24136219
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
[TBL] [Abstract][Full Text] [Related]
24. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma.
Lin YH; Wu MH; Huang YH; Yeh CT; Lin KH
Cells; 2020 Jan; 9(2):. PubMed ID: 31973032
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Value of Serum Biomarkers for Patients Undergoing Curative Resection with Non-B, Non-C Hepatocellular Carcinoma.
Li Y; Chen Y; Chen J
J Coll Physicians Surg Pak; 2020 Feb; 30(2):134-138. PubMed ID: 32036818
[TBL] [Abstract][Full Text] [Related]
26. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
[No Abstract] [Full Text] [Related]
27. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of hepatectomy for patients with non-hepatitis B, non-hepatitis C hepatocellular carcinoma.
Ochiai T; Ogino S; Ishimoto T; Toma A; Yamamoto Y; Morimura R; Ikoma H; Otsuji E
Anticancer Res; 2014 Aug; 34(8):4399-410. PubMed ID: 25075077
[TBL] [Abstract][Full Text] [Related]
29. Preoperative controlling nutritional status (CONUT) score predicts long-term outcomes in patients with non-B non-C hepatocellular carcinoma after curative hepatic resection.
Tsunematsu M; Haruki K; Fujiwara Y; Furukawa K; Onda S; Matsumoto M; Gocho T; Shiba H; Yanaga K
Langenbecks Arch Surg; 2021 Feb; 406(1):99-107. PubMed ID: 32936328
[TBL] [Abstract][Full Text] [Related]
30. Impact of occult hepatitis B virus infection on outcome after resection for non-B non-C hepatocellular carcinoma.
Wu ZF; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
J Surg Res; 2015 Jan; 193(1):153-60. PubMed ID: 25128925
[TBL] [Abstract][Full Text] [Related]
31. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
[TBL] [Abstract][Full Text] [Related]
32. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Non-B Non-C Hepatocellular Carcinoma with Reference to Patients with Interferon-Induced Hepatitis C Virus Eradication.
Shinkawa H; Tanaka S; Takemura S; Ito T; Aota T; Miyazaki T; Kubo S
J Gastrointest Surg; 2020 Aug; 24(8):1809-1817. PubMed ID: 31385170
[TBL] [Abstract][Full Text] [Related]
34. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.
Okuda Y; Mizuno S; Shiraishi T; Murata Y; Tanemura A; Azumi Y; Kuriyama N; Kishiwada M; Usui M; Sakurai H; Tabata M; Yamada T; Isaji S
Biomed Res Int; 2014; 2014():975380. PubMed ID: 24745029
[TBL] [Abstract][Full Text] [Related]
36. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
37. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
38. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
[TBL] [Abstract][Full Text] [Related]
39. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery.
Kondo K; Chijiiwa K; Funagayama M; Kai M; Otani K; Ohuchida J
J Gastrointest Surg; 2008 Mar; 12(3):468-76. PubMed ID: 17999119
[TBL] [Abstract][Full Text] [Related]
40. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
